DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Arthur Klausner to speak at the 13th Annual Drug Discovery & Development of Innovative Therapeutics (DDT) in Boston, MA
News | 08. 04. 2008
© 2020 Pappas Capital, LLC. ALL RIGHTS RESERVED.